Higher prices for MS drug help drug firm Merck
(AP)—Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in first-quarter profit.
Other
May 14, 2013 |
not rated yet |
0
Lundbeck profit jumps but warns on generic pressure
Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.
Medications
May 01, 2013 |
not rated yet |
0
Bayer profits up 11.5 percent on new drugs
German chemical and pharmaceutical company Bayer AG said Thursday that its net profit rose 11.5 percent in the first quarter as new drugs, led by blood thinner Xarelto, boosted sales.
Medications
Apr 25, 2013 |
not rated yet |
0
Novartis posts profit gain thanks to new drugs (Update)
(AP)—Swiss pharmaceutical company Novartis AG reported a 6.7 percent increase in profit for the first quarter Wednesday, boosted by new products and emerging markets.
Medications
Apr 24, 2013 |
not rated yet |
0
Merck Q4 net profit more than doubles
Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif multiple sclerosis drug and reaped rewards from its ongoing restructuring.
Other
Mar 07, 2013 |
2 / 5 (1) |
0
Lawsuit charges weigh on Bayer profits again
(AP)—Charges for lawsuits over its birth control pills weighed on Bayer AG's earnings once again during the fourth quarter of 2012.
Other
Feb 28, 2013 |
not rated yet |
0
Pfizer Q4 net jumps on sale of nutrition business
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. ...
Other
Jan 29, 2013 |
not rated yet |
0
Novartis Q4 net profit rebounds to $2.1 billion
(AP)—Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year.
Other
Jan 23, 2013 |
not rated yet |
0
Pfizer 3Q profit falls 14 pct on generic Lipitor (Update)
(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.
Other
Nov 01, 2012 |
not rated yet |
0
Belgian pharmaceuticals giant Solvay posts profit rise
Belgium's pharmaceuticals giant Solvay announced a better-than-expected 6.0 percent rise in net profit for the second quarter on Friday, sending its shares rising sharply.
Other
Jul 27, 2012 |
not rated yet |
0
